ARCHIVE
LONDON
REGENERATIVE MEDICINE NETWORK - FEBRUARY MEETING - Thursday
16th February 2006
The February meeting of the London
Regenerative Medicine Network will be held in the evening
of Thursday 16th February at King's College London
(Harris Lecture Theatre, Hodgkin Building,
Guy's Hospital Campus at London Bridge, London
SE1). The
meeting will include presentations by Dr. Anthony Mathur
(Barts and the London) - a clinician at the leading edge
of stem cell trials for heart failure, Dr. John Connolly
- Head of the Stem Cells and Cloning Policy at the Dept.
of Health, and the team behind VetCell; Greg
McGarrell/Dr. David Mountford who are pioneering stem
cell therapies in race horses. Now for a bit more detail
on all our speakers:
Dr.
Anthony Mathur
Dr Anthony Mathur is a Senior Lecturer and
Consultant Cardiologist at Barts and the London
NHS Trust as well as UCL Hospitals. Having completed a PhD
in stem cell biology at UCL he has continued to divide his
time equally between clinical medicine and research.
Anthony is secretary of the Task Force of
the European Society of Cardiology on the role of stem
cells in cardiovascular disease and also Chairs the
Clinical Group of the British Collaborative on
Stem Cell Repair of the Heart. Currently,
Anthony is leading the 700 patient REGENERATE clinical
trial to determine if a patient's own stem cells can be
used to treat heart disease:
http://news.bbc.co.uk/1/hi/health/4326698.stm
http://www.bartsandthelondon.org.uk/formedia/press/release.asp?id=915
Dr. John
Connolly
Dr. John Connolly is Head of Stem Cells and Cloning Policy
at the Department of Health and Secretary to the UK Stem
Cell Initiative. Recognising the increasing speed of
discovery and international competitiveness in the area of
stem cells, the UK Stem Cell Initiative (UKSCI) was
established by the Chancellor, Gordon Brown, in his March
2005 budget. The UKSCI, chaired by Sir John Pattison, was
charged with developing an overarching vision and costed
strategy for UK stem cell research over the next decade. In
December 2005, the UKSCI published its report and
recommendations. The strategy for the Initiative is
underpinned by 11 recommendations, each of which falls into
one of three categories: (i) strengthening infrastructure,
(ii) improving research funding or (iii) enhancing
coordination and communication.
http://www.advisorybodies.doh.gov.uk/uksci/index.htm
http://www.advisorybodies.doh.gov.uk/uksci/report-pressrelease1dec05.pdf
VetCell
Biosciences Ltd.
VetCell is the leading provider of stem cell technology to
the world of animal health. The Company was formed in
partnership with the Royal Veterinary College and the
Institute for Orthopaedic and Musculoskeletal Science to
develop the veterinary use of stem cell technologies. To
date the company has treated over 300 racehorses with stem
cells therapies.
Greg
McGarrell - Chief
Executive Officer
Greg has significant experience of start-ups and management
of SME’s within the animal health sector and advises
companies and veterinary practices on matters of business
development plus has successfully run his own veterinary
management consultancy. He has an MBA in Project Management
and Diploma in Management and is an inventor listed on the
first patent filed by VetCell.
Dr.
David Mountford -
Chief Operating Officer
David is a veterinary surgeon with management and
consultancy experience within the equine/animal health
sector. He has held successful European, Middle
Eastern, and Asian operational directorships; driven
strategic planning and operational change management at an
international level. David is Honorary Secretary of the
British Equine Veterinary Association, a Jockey Club
Veterinary Officer, and sits on the British Horse Industry
Confederation (BHIC).
http://www.vetcell.com
http://www.the-scientist.com/article/display/15804
This meeting is free of
charge to everyone through the generous support of
GlaxoSmithKline plus the kind assistance of the London
Biotechnology Network.
PLEASE NOTE THAT
DUE TO LECTURE THEATRE SEATING CAPACITY + CATERING
ARRANGEMENTS, IF YOU WISH TO ATTEND THIS EVENT YOU MUST
EMAIL THE SECRETARY, OTHERWISE UNFORTUNATELY YOU WILL NOT
BE ABLE TO GAIN ADMISSION.
Seat allocation is on a first come first served basis. If
you wish to attend, all that is required, is to email
the Network Secretary (secretary@regenmednetwork.com)
and type "Please add me to the guest list for February -
Thank you" or something similar!!!
AGENDA:
18.00 - Registration over tea and coffee
18.30 - Welcome - Dr. Chris Mason
(UCL) - Co-organiser of the
Network
18.35 - "Stem cells in heart
failure - the REGENERATE-IHD Clinical Trial" - Dr. Anthony
Mathur - Senior
Lecturer + Consultant Cardiologist - Barts and the London
NHS Trust
19.05 - Q+A Session
19.10 - "Stem cell therapies
for racehorses" - Greg McGarrell - CEO & Dr. David
Mountford - COO -
VetCell Biosciences Ltd.
19.40 - Q+A Session
19.45 - "The UK Stem Cell
Initiative" - Dr. John
Connolly - Head of
Stem Cells and Cloning Policy at the Department of Health
and Secretary to the UK Stem Cell Initiative
20.00 - Closing remarks - Dr. Stephen
Minger (King's) -
Co-organiser of the Network
20.10 - 22.00 - Networking reception - enjoy a glass of
wine or two...
Please only respond if you can definitely make the meeting.
Replies must go to secretary@regenmednetwork.com
(just hit the reply
button!)
We look forward to seeing everyone on Thursday 16th
February!
Stephen Minger + Chris Mason.
Co-organisers, London Regenerative Medicine Network.
www.regenmednetwork.com
PRINCIPLE
SPONSORS
Guy's, King's and St Thomas' Annual
Fund
London
Regenerative Medicine Network
"Bringing the regenerative medicine, stem cell and tissue
engineering community together..."